Related Experiment Video
Updated: Jul 19, 2026
08:20
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
Published on: August 17, 2022
Vaccines for preventing malaria (blood-stage)
1EpiVec Consulting, 606 Kimberly Lane NE, Atlanta, GA 30306, USA. epivec@comcast.net
The Cochrane Database of Systematic Reviews
|October 21, 2006
Summary
The MSP/RESA malaria vaccine may reduce malaria severity, but its effectiveness depends on the parasite subtype. Further development of blood-stage vaccines is warranted, though trial interpretations can be complex.
Area of Science:
- Malariology
- Vaccinology
- Infectious Diseases
Background:
- Malaria poses a significant global health burden, necessitating the development of effective vaccines.
- Blood-stage malaria vaccines target the asexual stages of the parasite, aiming to prevent infection, disease, and death.
- The MSP/RESA (Combination B) vaccine is one such candidate that has undergone randomized controlled trials.
Purpose of the Study:
- To evaluate the efficacy and safety of blood-stage malaria vaccines in preventing malaria infection, disease, and mortality.
- To assess the impact of the MSP/RESA vaccine on parasite density and clinical malaria episodes.
- To determine if the vaccine's effectiveness is specific to certain Plasmodium falciparum subtypes.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) involving blood-stage malaria vaccines (excluding SPf66) against Plasmodium species.
- Searched multiple databases including Cochrane, MEDLINE, EMBASE, LILACS, and Science Citation Index up to March 2006.
- Data extraction and quality assessment were performed independently by two authors, with results reported as relative risks and 95% confidence intervals.
Main Results:
- Five trials of the MSP/RESA vaccine involving 217 participants were included, with all reporting safety data and two reporting efficacy.
- No severe adverse effects were observed at the tested doses.
- The MSP/RESA vaccine showed a reduction in parasite density in children not pretreated with antimalarials and specifically reduced infections with the 3D7 subtype of MSP2, but not the FC27 subtype.
Conclusions:
- The MSP/RESA vaccine demonstrates potential in reducing malaria episode severity, with its efficacy being specific to the MSP2 variant.
- Antimalarial pretreatment in vaccine trials complicates interpretation, especially with small sample sizes.
- Blood-stage vaccines hold promise for malaria control and warrant continued research and development.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...